Site-less CRO model, What We’re Talking About This Week!

We start 2017 with Hot Topics about Center Point’s Site-less CRO model, the In Vitro Diagnostics market and the biggest R&D trends that we will see in the coming year! 1. ‘Site-less CRO’ model looks to evolve clinical trials Center Point Clinical Services has launched what it is calling the “world’s first site-less, technology CRO.” Read more here […]

CTMS Market, What We’re Talking About This Week!

  1.   Linking to health records will help drive CTMS market, says study The CTMS market is planned to show significant growth over the next few years. R&D investment is one driver, but the integration of CTMS with hospital information systems (HIS) is another very significant factor. 2.   Clinical Trials in Israel: Why […]

Clinical Trial Sites, What We’re Talking About This Week!

    1.  How to make training easier for clinical trial sites Addressing training methodologies will ‘go a long way’ in improving investigator satisfaction, according to a recent survey by Worldwide Clinical Trials. 2.  The Changing Role of the CRO and its Effect on Project Management Biotechs are leaning on CROs to help offset project […]

Technology in Clinical Trials, What We’re Talking About This Week

  1.  The Clinical Trial of the Future Technology in clinical trials is allowing for a new age of trials that are streamlined, connected and more engaged with the patient; but only if pharma can embrace the changes. 2. Is Industry Consolidation Stifling Pharma Innovation? In a year of “merger mania,” researchers suggest the elimination of competition […]

Diabetes Treatments, What We’re Talking About This Week

1.  The riskiest drugs to develop? Diabetes treatments, says Tufts report While the demand for new diabetes therapies grows, the development of endocrine drugs is riskier than all other drug development, according to a study conducted by the Tufts Center for the Study of Drug Development. 2.  Adverse Effects Underreported in Clinical Trials A recent […]

Remote Monitoring, What We’re Talking About This Week!

1. Remote Monitoring of Patients in Clinical Trials Technology is strongly influencing remote monitoring in clinical trials with the usage of mHealth and consumer wearables. Both factors helps make progress towards prevention and improving the efficiency of clinical trials. 2. Alleviating Disparities in Clinical Trials Patient Advocate Foundation has partnered with Sickle Cell Disease Association of Illinois and […]

Timely Clinical Trials, What We’re Talking About This Week!

The biggest challenges of timely clinical trials is one of our hot topics this week! 1.  The Biggest Challenges to Delivering Clinical Trials On-Time & Within Budget How clinical operations experts tackle some of the biggest barriers, such as data quality, when working toward delivering clinical trials on-time and within budget. 2. Researchers question traditional efficacy […]

Data Managers, What We’re Talking About This Week!

Data Managers and how their role has evolved leads our Hot Topics this week! 1.  Clinical Data and Integration Management: Discussing the Evolving Role of Data Managers We know the importance of Data Managers here at DZS! This is a great article that discusses the evolution of the role and the different factors that have changed […]

Osteoporosis, What We’re Talking About This Week!

Good news for those who suffer from osteoporosis and those who suffer from sickle cell in our Hot Topics this week! 1. Osteoporosis, a Disease With Few Treatment Options, May Soon Have One More A large clinical trial has resulted in very positive news for more than 10 million Americans who suffer from osteoporosis.  A […]

Zika Vaccine, What We’re Talking About This Week!

This week we are focusing on a Zika vaccine, plus digital health technologies and breast cancer study results! 1.   NIH begins testing investigational Zika vaccine in humans With around 80 volunteers, the NIH has launched a clinical trial of a Zika vaccine.  The vaccine was created with hopes of preventing infection of the deadly virus.  The early-stage […]